Syncona Limited (SYNC)
Category Alternative Other
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Sell
112.60p
Buy
113.40p
2.60p (+2.36%)
Discount/Premium
-39.96%
Estimated NAV
188.20p
Prices updated at 17 Jun 2024, 16:36 BST
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
To achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects. The Company will target an IRR per share across its investment portfolio of 15% p.a. over the long term. Over time, it is intended that the Company should invest the significant majority of its assets in Life Science Investments.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- Risk
- News & dates
- Trust info
- Director info
110.40 | |
Launch date | 26 Oct 2012 |
113.40p - 110.00p | |
160.80p - 105.00p | |
188.20 as of 31 Dec 2023 | |
Ongoing charge audited (%) | 0.88 |
0.93 | |
0.01 | |
0.00 | |
913,947.25 | |
647.02m | |
731.13m | |
99.35 | |
Annually | |
£1,217.69m | |
£1,217.69m | |
-36.15 | |
-31.44 | |
-12.88 | |
Fund comparative index | FTSE 250 TR GBP |
Quarterly | |
0.78m | |
0.96m | |
GG00B8P59C08 |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.